Mechanism of the pretreatment with electroacupuncture of "biaoben acupoint combination" for regulating cardiomyocyte mitochondrial fission in the rats of myocardial ischemia-reperfusion injury
Study on Mechanism|更新时间:2025-03-13
|
Mechanism of the pretreatment with electroacupuncture of "biaoben acupoint combination" for regulating cardiomyocyte mitochondrial fission in the rats of myocardial ischemia-reperfusion injury
Chinese Acupuncture & MoxibustionVol. 45, Issue 3, Pages: 335-344(2025)
ZHANG Yanlin, WU Song, GUO Qianru, et al. Mechanism of the pretreatment with electroacupuncture of "biaoben acupoint combination" for regulating cardiomyocyte mitochondrial fission in the rats of myocardial ischemia-reperfusion injury[J]. Chinese Acupuncture & Moxibustion, 2025, 45(3): 335-344. DOI: 10.13703/j.0255-2930.20240317-k0004.
DOI:
ZHANG Yanlin, WU Song, GUO Qianru, et al. Mechanism of the pretreatment with electroacupuncture of "biaoben acupoint combination" for regulating cardiomyocyte mitochondrial fission in the rats of myocardial ischemia-reperfusion injury[J]. Chinese Acupuncture & Moxibustion, 2025, 45(3): 335-344. DOI: 10.13703/j.0255-2930.20240317-k0004.DOI:
Mechanism of the pretreatment with electroacupuncture of "biaoben acupoint combination" for regulating cardiomyocyte mitochondrial fission in the rats of myocardial ischemia-reperfusion injury
To observe the effect of electroacupuncture (EA) pretreatment of "
biaoben
acupoint combination" on cardiomyocyte mitochondrial fission in the rats with myocardial ischemia-reperfusion injury (MIRI) and explore its mechanism.
Methods
2
Fifty male SD rats were randomly divided into a sham-operation group
a model group
an EA pretreatment group
an EA pretreatment + Compound C group and an EA pretreatment+ML385 group
10 rats in each group. In the EA pretreatment
the EA pretreatment + Compound C group and the EA pretreatment+ML385 group
EA was delivered at bilateral "Neiguan" (PC6)
"Zusanli" (ST36) and "Guanyuan" (CV4) for 20 min
with continuous wave and 2 Hz of frequency
1 mA of current
once daily for consecutive 7 days. On day 8
in the EA pretreatment + Compound C group and the EA pretreatment+ML385 group
30 min before model preparation
the intraperitoneal injection with Compound C (0.3 mg/kg) and ML385 (30 mg/kg) was administered respectively. Except in the sham-operation group
the ligation of the left anterior descending coronary artery was performed to prepare MIRI rat model in the rest groups. In the sham-operation group
the thread was not ligated. After modeling
the content of reactive oxygen species (ROS) in the ischemic area was measured by flow cytometry
superoxide dismutase (SOD) was detected using xanthine oxidase method
and malondialdelyde (MDA) was detected using thiobarbituric acid (TBA) chromatometry. The morphology of myocardial tissue in the ischemic area was observed with HE staining
and the mitochondria ultrastructure of cardiomyocytes observed under transmission electron microscopy. Using immunofluorescence analysis
the positive expression of mitochondrial fission factor (MFF)
mitochondrial fission 1 protein antibody (Fis1) and dynamin-related protein 1 (Drp1) was detected; and with immunohistochemical method used
the protein expression of adenosine monophosphate-activated protein kinase (AMPK)
nuclear factor E2-associated factor2 (Nrf2) and Drp1 in the ischemic area was detected.
Results
2
Compared with the sham-operation group
the content of ROS and MDA in the myocardial tissue of the ischemic area
and the positive expression of MFF
Fis1 and Drp1 increased in the model group (
P
<
0.01); the content of SOD and the protein expression of AMRK and Nrf2 decreased (
P
<
0.01)
and the protein expression of Drp1 elevated (
P
<
0.01). Compared with the model group
the content of ROS and MDA in the myocardial tissue of the ischemic area
and the positive expression of MFF
Fis1 and Drp1 were dropped in the EA pretreatment group (
P
<
0.01); the content of SOD and the protein expression of AMRK and Nrf2 rose (
P
<
0.01)
and the protein expression of Drp1 declined (
P
<
0.01); and in the EA pretreatment+Compound C group and the EA pretreatment+ML385 group
the positive expression of MFF
Fis1 and Drp1
and the protein expression of Drp1 were all reduced (
P
<
0.01). When compared with the EA pretreatment + Compound C group and the EA pretreatment+ML385 group
the content of ROS and MDA in the myocardial tissue of the ischemic area
and the positive expression of MFF
Fis1 and Drp1 were dropped in the EA pretreatment group (
P
<
0.01); the content of SOD and the protein expression of AMRK and Nrf2 rose (
P
<
0.01
P
<
0.05)
and the protein expression of Drp1 decreased (
P
<
0.05). In comparison with the model group
the EA pretreatment+Compound C
group and the EA pretreatment+ML385 group
the cardiac muscle fiber rupture
cell swelling and mitochondrial disorders were obviously alleviated in the EA pretreatment group. The morphological changes were similar among the model group
the EA pretreatment+Compound C group and the EA pretreatment+ML385 group.
Conclusion
2
Electroacupuncture pretreatment of "
biaoben
acupoint combination" attenuates myocardial injury in MIRI rats
probably through promoting the phosphorylation of AMPK and Nrf2
inhibiting the excessive mitochondrial fission induced by Drp1
and reducing mitochondrial dysfunction caused by mitochondrial fragmentation and vacuolation.
Mechanism of "biaoben acupoint combination" electroacupuncture pretreatment in alleviating cardiomyocyte cuproptosis in rats with myocardial ischemia-reperfusion injury
Regulatory effect of electroacupuncture at "Neiguan" (PC6) on mitochondrial autophagy during the ischemia and reperfusion phases in rats with myocardial ischemia-reperfusion injury
Effect of electroacupuncture on microglial activation in the lumbar spinal cord of rabbits with lumbar intervertebral disc degeneration
Electroacupuncture promotes browning of white adipose tissue by regulating mTOR/SREBP1 signaling pathway in obese mice
Clinical efficacy and cost-effectiveness evaluation of acupoint thread-embedding for knee osteoarthritis of early to middle stage
Related Author
WEI Yuqi
ZHANG Yanlin
WAN Xiaoman
MAO Jing
WANG Sunyi
JIANG Chunyan
CAO Zhenyang
GUO Qianru
Related Institution
College of Acupuncture-Moxibustion and Orthopedics, Hubei University of CM, Hubei Provincial Collaborative Innovation Center of Preventive Treatment of Diseases by Acupuncture and Moxibustion
Department of Acupuncture-Moxibustion, Affiliated Hospital of Hubei University of CM, Hubei Provincial Hospital of TCM
School of Acupuncture-Moxibustion and Tuina, Beijing University of CM
Department of Orthopedics, Guangyuan Second People's Hospital
Department of General Medicine, Guangyuan Maternal and Child Health Hospital